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Lissencephaly is a severe brain malformation associated with abnormal formation of cerebral sulci. Until now, many genes
related to lissencephaly have been identified. Among them, classical lissencephaly has been often related to the platelet acti-
vating factor acetylhydrolase 1B regulatory subunit 1 gene (PAFAH1B1). We identified a novel PAFAH1B1 splicing variant
(NM_000430.3:c.118-2A>G) in a female patient with classical lissencephaly manifesting as developmental delay, growth
failure, and epilepsy. This variant was not detected in her parents, indicating de novo occurrence of the variant in the patient.
To confirm whether this variant is in fact related to splicing error, RNA expression was analyzed. As suspected, an abnormal
short band excluding exon 4 was additionally detected. This evidence confirmed that the novel variant is definitely patho-
genic to cause lissencephaly in the patient.
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Introduction
Lissencephaly is one of the malformations of the brain,
which manifests as abnormal formation of cerebral sulci.
Through radiological examination using magnetic reso-
nance imaging (MRI), lissencephaly has been classified




tions are related to genetic classifications. Miller-Dieker
syndrome has been established as one of the congenital
malformation syndromes and it has been related to the
subtelomeric deletion of 17 p.
２
Patients with Miller-
Dieker syndrome (MIM #247200) show classical lissen-
cephaly and facial dysmorphism. Thus, genes related to
these clinical features had been suspected to be localized
in 17p. In 1993, the platelet activating factor acetylhydro-
lase 1B regulatory subunit 1 gene (PAFAH1B1; former
name LIS1) located on 17p was isolated as the gene re-
sponsible for lissencephaly.
３
Later, the tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation
protein epsilon gene (YWHAE), which is located more to-
wards the telomeric region and at a distance from PA-
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Figure　1　Brain magnetic resonance imaging of the patient. (A) An axial T1-weight image shows 
agyria and thick cortical surface. (B) A sagittal T1-weighted image shows reduced volume of the brain.
A B
FAH1B1, was identified as the gene related to facial dys-
morphism.
４
Recently developed equipments for genomic analysis
have promoted the understanding of the genomic basis of
lissencephaly. Many genes, including the reelin (RELN),
the tubulin alpha 1a (TUBA1A) , and the doublecortin
(DCX) genes, have been identified as the genes responsi-
ble for brain malformation. Intriguingly, PAFAH1 B 1-
associated lissencephaly, included in Online Mendelian
Inheritance in Man
Ⓡ
(https://omim.org/) as an autosomal
dominant disease of Lissencephaly 1 (MIM #607432),




nucleotide variants of PAFAH1B1 have been reported.７，８
Here, we have identified a novel disease-causing
variant of PAFAH 1 B 1 in a patient with classical
lissencephaly. As the identified variant was located on
the splicing acceptor site, abnormal splicing pattern was
confirmed by molecular analysis.
Case Report
A 4-month-old girl was born at 39 weeks and 5 days of
gestation with birth weight of 2,370 g, height of 42.6 cm,
and occipitofrontal circumference (OFC) of 31.7 cm.
Apgar score was 7 / 9, indicating that there was no
asphyxia at birth. Because dilatation of bilateral
ventricles had been suggested after fetal ultrasound at 36
weeks of gestation, the girl was admitted to neonatal
intensive care unit at birth. On 6th day after delivery,
brain magnetic resonance imaging ( MRI ) revealed
lissencephaly associated with no gyrus formation on the
surface of the cerebrum (Figure 1). After discharge from
the hospital, she started to show myoclonus-like
movements. Although phenobarbital was prescribed for
several weeks, she began to suffer from series of
epileptic spasms and admitted to our hospital when she
was months old.
At the time of admission, her height was 55.5 cm
(－4.0 SD), weight was 4.9 kg (－2.4 SD), and OFC was
37.0 cm (－ 3.1 SD ) , indicating growth failure and
microcephaly. There was no dysmorphic finding. Vital
signs were within normal limit. On neurological
examination, generalized hypotonia was noted because of
which she had poor head control. Routine laboratory
examination showed no abnormality ; however,
electroencephalogram revealed atypical hypsarrhythmia
(Figure 2), indicating West syndrome. Hence, the girl
was started on adrenocorticotropic hormone therapy.
For precise diagnosis, genetic diagnosis was
performed. Fluorescence in-situ hybridization ( FISH )
showed no deletion in the 17 p 13.3 region, which is
responsible for Miller-Dieker syndrome. Thus,
comprehensive genomic analysis was performed. After
obtaining written informed consent from her parents,
peripheral blood samples were collected from the patient
and her parents. This study was performed in accordance
with the Declaration of Helsinki and was approved by the
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Gene Analysis Research Ethics Committee of Tokyo
Women’s Medical University ( No. 341 B ) . Genomic
DNA was extracted from the blood samples using a
QIAamp DNA extraction kit (Qiagen, Hilden, Germany).
Next-generation sequencing ( NGS ) was performed to
screen single-nucleotide variants using TruSight One ver
1.0 sequencing panel (Illumina, San Diego, CA, USA) as
described previously.
９
The extracted data were mapped to
a reference genome (GRCh37/hg19) using the BWA
Enrichment ver 1.0 cloud software ( Illumina ) , and
annotated and filtered using the Variant Studio software
(Illumina).
After filtering the data, a novel heterozygous variant
was detected in the splicing acceptor site of exon 4 of
PAFAH1B1 (NM_000430.3:c.118-2A>G). There was no
possible candidate variant in other genes related to
lissencephaly. Sanger sequencing confirmed the
existence of this variant in the patient but not in her
parents (Figure 3A). This indicated de novo occurrence
of the variant. To further confirm whether this variant did
in fact cause the splicing abnormality, expressed RNA
was examined. Total RNA extracted from Epstein-Barr
virus-transformed leukocytes was reverse-transcribed
(RT) into complimentary DNA (cDNA). The cDNA was
amplified by RT-PCR as described previously.
１０
The
result showed the presence of an abnormal short band in
addition to the normal band (Figure 3B). By use of DNA
extraction kit (Qiagen), DNA amplicons were extracted
through separated bands of both a normal- and an
abnormal short band. Sanger sequencing performed using
the extracted DNA samples confirmed exon 4 skipping
(Figure 3C).
Discussion
In this study, we reported a patient with classical
lissencephaly. The patient presented with developmental
delay, hypotonia, and epileptic spasms. These clinical
findings were typical of the clinical course of
lissencephaly. According to the previously proposed
classification of classic lissencephaly, brain MRI findings
of this patient were considered as grade 1.
１１
From this
radiological pattern, PAFAH1 B 1 located on 17 p was
suspected as the most possible candidate gene.
１２
However, chromosomal deletion involving 17 p was
dismissed based on the results of FISH. PAFAH 1 B 1
―88―
Figure　3　Results of molecular analyses. (A) Genomic sequence for the patient shows a nucleotide 
alteration (a>g) in the splicing acceptor site of exon 4, whereas control shows the wild type sequence. 
(B) Electrophoresis of the amplicons obtained after reverse transcribed (RT)-PCR revealed an addi-
tional short band (Band 2) in addition to the normal band (Band 1) in the patient. (C) Sanger sequence 
for Band 2 confirmed exon 4 skipping, whereas Band 1 (expected to be derived from the normal allele) 
showed normal pattern.
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consists of as many as 10 exons and there are more than
10 possible candidate genes of lissencephaly other than
PAFAH 1 B 1. Thus, comprehensive genomic analysis
using TruSight One was considered as a more efficient
way for examining the status of candidate genes than
targeted Sanger sequencing.
As suspected, a de novo variant was identified in
PAFAH1B1. Splice variants are rare in PAFAH1B1.１３ We
confirmed exon skipping by RT-PCR and subsequent
Sanger sequencing. The exon 4 that was deleted in the
patient consists of multiples of three nucleotides. Thus,
exon 4 skipping was predicted to cause in-frame deletion
and not frame-shift deletion. Generally, frameshift leads
to premature termination and subsequent nonsense-
mediated mRNA decay. Thus, frameshift variants are
usually related to loss-of-function and most of the
variants identified in PAFAH1B1 are related to loss-of-
function.
１３
In comparison, in-frame deletions are
generally related to milder phenotypes in genetic
disorders ; however, in this case, exon 4 encodes an




exon 4 skipping was considered to be related to loss-of-
function mechanism.
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